These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27829066)

  • 1. Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.
    Martinez-Martinez E; Ibarrola J; Calvier L; Fernandez-Celis A; Leroy C; Cachofeiro V; Rossignol P; Lopez-Andres N
    PLoS One; 2016; 11(11):e0166272. PubMed ID: 27829066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.
    Martínez-Martínez E; Ibarrola J; Fernández-Celis A; Calvier L; Leroy C; Cachofeiro V; Rossignol P; López-Andrés N
    J Hypertens; 2018 Feb; 36(2):368-376. PubMed ID: 28858976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.
    Martínez-Martínez E; López-Ándres N; Jurado-López R; Rousseau E; Bartolomé MV; Fernández-Celis A; Rossignol P; Islas F; Antequera A; Prieto S; Luaces M; Cachofeiro V
    Hypertension; 2015 Nov; 66(5):961-9. PubMed ID: 26351031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model.
    Ibarrola J; Martínez-Martínez E; Sádaba JR; Arrieta V; García-Peña A; Álvarez V; Fernández-Celis A; Gainza A; Rossignol P; Cachofeiro Ramos V; López-Andrés N
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.
    Calvier L; Martinez-Martinez E; Miana M; Cachofeiro V; Rousseau E; Sádaba JR; Zannad F; Rossignol P; López-Andrés N
    JACC Heart Fail; 2015 Jan; 3(1):59-67. PubMed ID: 25458174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
    Martínez-Martínez E; Calvier L; Fernández-Celis A; Rousseau E; Jurado-López R; Rossoni LV; Jaisser F; Zannad F; Rossignol P; Cachofeiro V; López-Andrés N
    Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity.
    Li HY; Yang S; Li JC; Feng JX
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30455396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 inhibition prevents adipose tissue remodelling in obesity.
    Martínez-Martínez E; Calvier L; Rossignol P; Rousseau E; Fernández-Celis A; Jurado-López R; Laville M; Cachofeiro V; López-Andrés N
    Int J Obes (Lond); 2016 Jun; 40(6):1034-8. PubMed ID: 26853916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis.
    Arrieta V; Martinez-Martinez E; Ibarrola J; Alvarez V; Sádaba R; Garcia-Peña A; Fernández-Celis A; Cachofeiro V; Rossignol P; López-Andrés N
    Clin Sci (Lond); 2017 May; 131(10):935-949. PubMed ID: 28360193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury.
    Kolatsi-Joannou M; Price KL; Winyard PJ; Long DA
    PLoS One; 2011 Apr; 6(4):e18683. PubMed ID: 21494626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
    Ibarrola J; Matilla L; Martínez-Martínez E; Gueret A; Fernández-Celis A; Henry JP; Nicol L; Jaisser F; Mulder P; Ouvrard-Pascaud A; López-Andrés N
    Sci Rep; 2019 Jul; 9(1):9607. PubMed ID: 31270370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 mediates aldosterone-induced vascular fibrosis.
    Calvier L; Miana M; Reboul P; Cachofeiro V; Martinez-Martinez E; de Boer RA; Poirier F; Lacolley P; Zannad F; Rossignol P; López-Andrés N
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):67-75. PubMed ID: 23117656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.
    Marín-Royo G; Gallardo I; Martínez-Martínez E; Gutiérrez B; Jurado-López R; López-Andrés N; Gutiérrez-Tenorio J; Rial E; Bartolomé MAV; Nieto ML; Cachofeiro V
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.
    Frenay AR; Yu L; van der Velde AR; Vreeswijk-Baudoin I; López-Andrés N; van Goor H; Silljé HH; Ruifrok WP; de Boer RA
    Am J Physiol Renal Physiol; 2015 Mar; 308(5):F500-9. PubMed ID: 25503732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
    Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.
    Abu-Elsaad NM; Elkashef WF
    Can J Physiol Pharmacol; 2016 May; 94(5):554-62. PubMed ID: 27010252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of galectin-3 in autoimmune and non-autoimmune nephropathies.
    Saccon F; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    Autoimmun Rev; 2017 Jan; 16(1):34-47. PubMed ID: 27666815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of modified citrus pectin on galectin-3 inhibition in cisplatin-induced cardiac and renal toxicity.
    Santos DD; Belote NM; Sasso GRS; Correia-Silva RD; Franco PC; da Silva Neto AF; Borges FT; Oyama LM; Gil CD
    Toxicology; 2024 May; 504():153786. PubMed ID: 38522819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-8 counteracts folic acid-induced acute kidney injury and prevents its transition to fibrosis.
    Perez-Moreno E; Toledo T; Campusano P; Zuñiga S; Azócar L; Feuerhake T; Méndez GP; Labarca M; Pérez-Molina F; de la Peña A; Herrera-Cid C; Ehrenfeld P; Godoy AS; González A; Soza A
    Biomed Pharmacother; 2024 Aug; 177():116923. PubMed ID: 38936192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic Effects of Modified Citrus Pectin.
    Eliaz I; Raz A
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.